Birth Control Pill Has Prevented 100,000 Deaths in Past 50 Years

May 2008
ONS Connect;May2008, Vol. 23 Issue 5, p8
Academic Journal
The article discusses research being done on the prevention of ovarian cancer deaths by the use of contraceptive pill. It references a study by V. Beral et al published in the 2008 issue of "Lancet." The results of the study reveal that using oral contraceptives reduces women's risk of developing ovarian cancer. It shows that the longer use of oral contraceptives results to a bigger reduction in risk of ovarian cancer. It also shows that the risk reduction persisted for more than 30 years after women stopped taking the pill.


Related Articles

  • Biological Diversity of Ovarian Cancer Lessens Value of Screening.  // International Journal of Cancer Research;2011, Vol. 7 Issue 2, p164 

    No abstract available.

  • Use of oral contraceptives linked to a lower risk of ovarian cancer. Arias, Donya C. // Nation's Health;Mar2008, Vol. 38 Issue 2, p22 

    The article presents a study on the link between oral contraceptive use and lowered risk for ovarian cancer. Published in the January 26, 2008 issue of "Lancet," the study found that the longer women used oral contraceptives, the greater the reduction in ovarian cancer risk. The lowered risk...

  • Risk of malignancy index is not sensitive in detecting non-epithelial ovarian cancer and borderline ovarian tumor. Meray, Onur; Türkçüoğlu, Ilgın; Meydanlı, Mehmet Mutlu; Kafkaslı, Ayşe // Journal of the Turkish-German Gynecological Association;Mar2010, Vol. 11 Issue 1, p22 

    Objective: To determine the value of risk of malignancy index in detection of ovarian cancer and referral of adnexal masses. Material and Method: Patients scheduled for surgery due to adnexal mass between May 2008 and August 2009 were prospectively included in the study. Risk of malignancy index...

  • Co-existence of breast and ovarian cancers in BRCA germ-line mutation carriers. Dilawari1, A.; Cangiarella, J.; Smith, J.; Huang, A.; Downey, A.; Muggia, F. // Ecancermedicalscience;2008, Vol. 2, p1 

    The co-existence of breast and ovarian cancers in the same individual should raise suspicion of a hereditary process. Patients with either BRCA1 or BRCA2 germ-line mutations have an average risk of 39% and 11% respectively of developing ovarian cancer by the age of 70; they have a risk of 35-85%...

  • Evidence shows Pill may offer protection from ovarian cancer.  // Practice Nurse;2/8/2008, Vol. 35 Issue 3, p6 

    The article focuses on a report published in "The Lancet," which reveals that the combined oral contraceptive pill gives women substantial and long-lasting protection against ovarian cancer. The research team estimated that, in high income countries, using oral contraceptives for 10 years...

  • BRCA Mutations Lessen Protective Effect of Pill Against Ovarian Cancer. Rosenberg, J. // Family Planning Perspectives;Nov/Dec2001, Vol. 33 Issue 6, p286 

    This article focuses on the protective effect of pill against ovarian cancer. The protective effects against ovarian cancer of parity and oral contraceptive use differ depending on whether women have mutations of the BRCA1 or the BRCA2 gene. Overall, women who have had children and those who...

  • Risk of Ovarian Cancer is Lessened by Childbearing, Pill Use and Hysterectomy. Hollander, D. // Family Planning Perspectives;Mar/Apr95, Vol. 27 Issue 2, p94 

    This article reports that childbearing, oral contraceptive use and hysterectomy appear to protect women against the risk of developing ovarian cancer, according to the findings of a case-control study conducted in Ontario. Women who used the pill for one year were one-half as likely as nonusers...

  • Analysis of Perception, Attitude and Utilization of Oral Contraceptives among Population with History of Breast Cancer and Ovarian Cancer. LI Hong // Journal of International Obstetrics & Gynecology;Dec2013, Vol. 40 Issue 6, p568 

    Objective: To investigate the perception, attitude, and utilization of oral contraceptives (OC) among population with history of breast cancer and ovarian cancer. Methods; All of 92 females who had history of breast cancer and ovarian cancer among first level relatives were surveyed on...

  • The expression of BRCA1, P53, KAI1, and Nm23 in ovaries of BRCA1 mutation carriers after prophylactic adnexectomy. Markowska, J.; Bar, J.; Mądry, R.; Słomska, I.; Mardas, M.; Grabowski, J. // Archives of Gynecology & Obstetrics;Oct2013, Vol. 288 Issue 4, p839 

    Introduction: High mortality rate, absence of reliable methods for early diagnosis and poor prognosis of advanced ovarian cancer prompted to investigate the role of prophylactic oophorectomy in BRCA1 mutation carriers as well as evaluate the expression of BRCA1, p53, Nm23, and KAI1 proteins in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics